Celldex Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
CLDX Nasdaq 2836 https://celldex.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Celldex Therapeutics, Inc.

Celldex Therapeutics Full Year 2022 Earnings: Revenues Beat Expectations, EPS In Line - Mar 2nd, 2023 10:40 am
Celldex Reports Fourth Quarter and Year End 2022 Financial Results and Provides Corporate Update - Feb 28th, 2023 9:01 pm
Why Celldex Therapeutics Shares Are Trading Higher Today - Feb 27th, 2023 3:25 pm
Celldex Therapeutics Presents Positive Data from Barzolvolimab Phase 1b Study in Chronic Spontaneous Urticaria at AAAAI 2023 - Feb 26th, 2023 2:00 pm
Celldex Therapeutics Announces Appointment of Rita Jain, M.D. to Board of Directors - Feb 16th, 2023 9:01 pm
Celldex Therapeutics to Present at SVB Securities Global Biopharma Conference - Feb 15th, 2023 12:00 pm
Celldex Therapeutics Announces Upcoming Presentation of Barzolvolimab Phase 1b Results in Chronic Spontaneous Urticaria at American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting 2023 - Feb 3rd, 2023 12:01 pm
As Celldex Recovers, Here's My Strategy - Jan 18th, 2023 7:38 pm
Celldex Therapeutics Presents Positive Data from Barzolvolimab Phase 1b Study in Chronic Inducible Urticaria at Global Urticaria Forum 2022 - Dec 6th, 2022 11:00 am
Celldex Therapeutics Announces Multiple Upcoming Presentations of Barzolvolimab Data at GA²LEN Global Urticaria Forum (GUF) 2022 - Dec 2nd, 2022 2:31 pm
We're Hopeful That Celldex Therapeutics (NASDAQ:CLDX) Will Use Its Cash Wisely - Nov 27th, 2022 2:45 pm
Celldex to Participate in Upcoming November Investor Conferences - Nov 10th, 2022 9:01 pm
Celldex Therapeutics (CLDX) Reports Q3 Loss, Tops Revenue Estimates - Nov 9th, 2022 10:25 pm
Celldex Reports Third Quarter 2022 Financial Results and Provides Corporate Update - Nov 9th, 2022 9:01 pm
Spero Therapeutics, Inc. (SPRO) Expected to Beat Earnings Estimates: Should You Buy? - Nov 2nd, 2022 2:01 pm
Earnings Preview: Celldex Therapeutics (CLDX) Q3 Earnings Expected to Decline - Nov 1st, 2022 2:01 pm
Celldex Therapeutics (CLDX) Reports Q2 Loss, Lags Revenue Estimates - Aug 8th, 2022 9:25 pm
Celldex Reports Second Quarter 2022 Financial Results and Provides Corporate Update - Aug 8th, 2022 8:01 pm
Celldex Announces First Patient Dosed in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria - Jul 21st, 2022 12:00 pm
Billionaire Andreas Halvorsen Bets Big on These 2 High-Upside Stocks - Jul 8th, 2022 1:26 pm